Literature DB >> 3134412

Ultrasonic mensuration of fetal limb bones in the second and third trimesters.

E Merz1, M S Kim-Kern, S Pehl.   

Abstract

Growth of fetal limb bones has been examined in a prospective cross-sectional study in 530 patients between 13 and 42 weeks of gestation by ultrasound. The length of the femur, tibia, humerus, and radius were measured in all cases, and fibula and ulna in 393 cases. For each week of gestation mean lengths (+/- 2 standard deviations) were calculated. All limb bones showed linear growth from 13 weeks to 25 weeks of gestation, after which the growth curve appeared nonlinear. A strong linear relationship (r greater than 0.98) between the BPD and bone length was found for each bone. In five aborted fetuses, prenatal sonographic measurements of the ossified diaphyses were compared with the postnatal radiologic measurement (30 limb bones). A good agreement was found (difference between ultrasound and X-ray measurements 0.7 +/- 0.5 [SD] mm or 3.0 +/- 2.4 [SD]%), indicating that ultrasound images the ossified diaphysis.

Entities:  

Mesh:

Year:  1987        PMID: 3134412     DOI: 10.1002/jcu.1870150305

Source DB:  PubMed          Journal:  J Clin Ultrasound        ISSN: 0091-2751            Impact factor:   0.910


  3 in total

1.  The prenatal development of the normal human skeleton: a combined ultrasonographic and post-mortem radiographic study.

Authors:  H J van der Harten; J T Brons; N W Schipper; P F Dijkstra; C J Meijer; H P van Geijn
Journal:  Pediatr Radiol       Date:  1990

Review 2.  Evaluating skeletal dysplasias on prenatal ultrasound: an emphasis on predicting lethality.

Authors:  Kathryn S Milks; Lyndon M Hill; Keyanoosh Hosseinzadeh
Journal:  Pediatr Radiol       Date:  2016-12-01

3.  Leukocyte adhesion deficiency II syndrome, a generalized defect in fucose metabolism.

Authors:  T Marquardt; T Brune; K Lühn; K P Zimmer; C Körner; L Fabritz; N van der Werft; J Vormoor; H H Freeze; F Louwen; B Biermann; E Harms; K von Figura; D Vestweber; H G Koch
Journal:  J Pediatr       Date:  1999-06       Impact factor: 4.406

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.